Positive effect of ursodeoxycholic acid therapy on liver enzyms in chronic active autoimmune hepatitis - A pilot study;Positiver effekt der ursodeoxycholsäure auf die leberenzyme bei der wenig aktiven autoimmunhepatitis - Eine pilotstudie

Leber Magen Darm

Volumn 26, Issue 6, 1996, Pages 310-313

  Janowitz, P ^a,d   Kratzer, W ^b   Wechsler, J G ^c  

^a Krankenhaus Burg   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^d Kreiskrankenhaus Burg ^*  (Germany)

Author keywords

ANA; Autoimmune hepatitis; Chenodeoxycholic acid; Lithocolic acid; Primary biliary cirrhosis; Primary sclerosing cholangitis; SMA ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CHOLAGOGUE; ENZYME; SM NUCLEAR ANTIGENS; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; AUTOIMMUNE DISEASE; BLOOD; CHRONIC HEPATITIS; ENZYMOLOGY; LIVER FUNCTION TEST; PILOT STUDY;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHOLAGOGUES AND CHOLERETICS; ENZYMES; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE; PILOT PROJECTS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; URSODEOXYCHOLIC ACID;

EID: 0029658477     PISSN: 03008622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Soloway, R.D., Summerskill, W.H.J., Baggenstoss, A.H., et al.: Clinical biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63, 820-833 (1972)
2. De Groote, J., Fevery, J., Lepoutre, L.: Long term follow-up of chronic active hepatitis of moderate severity. Gut 19, 510-513 (1978)
3. Bijeveld, C.M.A., Vonk, R.J., Kuipers, F., et al.: Bening reccurent intrahepatic cholestasis: a long-term follow-up study of two patients. Hepatology 9, 532-537 (1989)
4. Chazouilleres, O., Poupon, R., Capron, J.-P., Metman, E.-H., Dhumeau, D., Amouretti, M., Couzigou, P., Labayle, D., Trinchet, J.C.: Ursodeoxycholic acid for primary sclerosing cholangitis. J. Hepatol. 11, 120-123 (1990)
5. Leuschner, U., Leuschner, M., Sieratzki, J., Kurtz, W., Hübner, K.: Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig. Dis. Sci. 30, 642-649 (1985)
6. Poupon, R., Chretien, Y., Poupon, R.E., et al.: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1, 834-836 (1987)
7. Ullrich, D., Rating, D., Schröter, W., et al.: Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 2, 1324 (1987)
8. Podda, M., Ghezzi, C., Battezzati, P.M., Crosignani. A., Zuin, M., Roda, A.: Effect of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 93, 1044-1050 (1990)
9. Rolandi, E., Franceschini, R., Cataldi, A., Cicchetti, V., Carati, L., Barreca, T.: Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. Eur. J. Clin. Pharmacol. 40, 473-476 (1991)
10. Dixon, W.J., Brown, M.B., Engelman, L., et al.: BMDP Statistical Software. University of California press, Berkeley, Los Angeles, London 1985
11. Bellentiani, S., Tabarroni, G., Barchi, T., Ferretti, I., Fratli, N., Villa, E., Manenti, F.: Effect of ursodeoxycholic acid treatment on alanine aminotransferase and γ-glutamyltranspeptidase serum levels in patients with hypcrtransaminasemia. Results from a double-blind controlled trial. Journal of Hepatology 8, 7-12 (1989)
12. Joske, R.A., King, W.E.: The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet II, 477-480 (1955)
13. Veto, S., Hegarty, J.E., Bottazzo, G., et al.: Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet I, 1200-1204 (1984)
14. Hachiya, H., Hayakawa, T., Katagiri, K., Ohnishi, H., Kawamura, Y., Takeshima, A., Yoshioka, N., Hoshino, M., Tsukada, K., Miyaji, M., Takeuchi, T.: Ursodeoxycholic acid-induced choleresis in isolated rat liver perfusion. Acta Hepatologica Japonica 28, 1106 (1987)
15. Hardison, W.G.M., Grundy, S.M.: Effect of ursodeoxycholic acid and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 87, 130-135 (1984)
16. + exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated ursodeoxycholate, an increased ursodeoxycholate glucuronidation. Gastroenterology 95, 454-463 (1988)
17. Duane, W.C., Bjoerkhem, I., Hamilton, J.N., Mueller, S.M.: Quantitative importance of the 25-hydroxylation pathway for bile acid biosynthesis in the rat. Hepatology 8, 613-618 (1990)
18. Ferrari, A., Pacini, N., Sinon, C.R., Kritchevsky, D.: In vitro transformation of cheno- and ursodeoxycholic acids and their 7-oleyl esters by human intestinal microflora. Proceedings of the Society for Experimental Biology and Medicine 188, 108-111 (1988)
19. Heuman, D.M., Hernandez, C.R., Hylemon, P.B., Kubaska, W.M., Hartman, C., Vlahcevic, Z.R.: Regulation of bile acid synthesis I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat. Hepatology 8, 358-365 (1988)
20. Paumgartner, G.: Einfluß der Ursodeoxycholsäure auf die Sekretion der Galle. Z. Gastroenterol. (Verh. 24), 123-124 (1989)
21. Stiehl, A., Raedsch, R., Rudolph, G.: Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment. Gastroenterology 94, 1201-1206 (1988)
22. Federowski, T., Salen, G., Colallilo, A,. Tint, G.S., Mosbach, E.H., Hall, J.C.: Metabolism of ursodeoxycholic acid in man. Gastroenterology 73, 1131-1137 (1977)
23. Osuga, T., Tanaka, N., Matsuzaki, Y., Aikawa, T.: Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis. Dig. Dis. Sci. 34, 495-515 (1989)
24. Calmus, Y., Gane, P., Rouger, P., Poupon, R.: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11, 12-15(1990)
25. Fried, R.H., Murakami, C.S., Fisher, L.D., Wilson, R.A., Sullivan, K.M., McDonald, G.B.: Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Annuals of Internal Medicine 116, 624-629 (1990)
26. Podda, M., Ghezzi, C., Battezzati, P.M., Bertolini, A., Crosignani, A., Petroni, M.L., Zuin, M.: Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig. Dis. Sci. 34, 59-65 (1989)